Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
22,850
+50 (0.22%)
At close: Apr 2, 2026
Market Cap159.24B +49.3%
Revenue (ttm)64.29B -10.3%
Net Income1.17B
EPSn/a
Shares Out6.97M
PE Ratio136.59
Forward PEn/a
Dividend1,200.00 (5.33%)
Ex-Dividend DateDec 29, 2025
Volume4,563
Average Volume6,032
Open23,200
Previous Close22,800
Day's Range21,850 - 23,200
52-Week Range14,500 - 31,450
Beta-0.28
RSI47.03
Earnings DateFeb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements